
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury
Rabea Hinkel, Deepak Ramanujam, Veronika Kaczmarek, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 15, pp. 1788-1800
Open Access | Times Cited: 115
Rabea Hinkel, Deepak Ramanujam, Veronika Kaczmarek, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 15, pp. 1788-1800
Open Access | Times Cited: 115
Showing 26-50 of 115 citing articles:
Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis
Cong Chen, Jie Wang, Shan Zhang, et al.
Redox Biology (2024) Vol. 76, pp. 103321-103321
Open Access | Times Cited: 6
Cong Chen, Jie Wang, Shan Zhang, et al.
Redox Biology (2024) Vol. 76, pp. 103321-103321
Open Access | Times Cited: 6
miR-21, Mediator, and Potential Therapeutic Target in the Cardiorenal Syndrome
Cheng-Kai Huang, Christian Bär, Thomas Thum
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 42
Cheng-Kai Huang, Christian Bär, Thomas Thum
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 42
Cardiovascular consequences of viral infections: from COVID to other viral diseases
Heinz‐Peter Schultheiß, Christian Baumeier, Heiko Pietsch, et al.
Cardiovascular Research (2021)
Open Access | Times Cited: 39
Heinz‐Peter Schultheiß, Christian Baumeier, Heiko Pietsch, et al.
Cardiovascular Research (2021)
Open Access | Times Cited: 39
Therapeutic miR-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease
Carolina Kymie Vasques Nonaka, Gabriela Louise de Almeida Sampaio, Luciana de Aragão França, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3307-3307
Open Access | Times Cited: 36
Carolina Kymie Vasques Nonaka, Gabriela Louise de Almeida Sampaio, Luciana de Aragão França, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3307-3307
Open Access | Times Cited: 36
New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic Strategies
Yuanyuan Zhao, Dunfeng Du, Shanshan Chen, et al.
Genes (2022) Vol. 13, Iss. 8, pp. 1390-1390
Open Access | Times Cited: 25
Yuanyuan Zhao, Dunfeng Du, Shanshan Chen, et al.
Genes (2022) Vol. 13, Iss. 8, pp. 1390-1390
Open Access | Times Cited: 25
The Roles of microRNAs in the Cardiovascular System
Francesco Nappi, Sanjeet Singh, Vikram Jitendra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14277-14277
Open Access | Times Cited: 14
Francesco Nappi, Sanjeet Singh, Vikram Jitendra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14277-14277
Open Access | Times Cited: 14
Evidence and perspectives on miRNA, circRNA, and lncRNA in myocardial ischemia-reperfusion injury: a bibliometric study
Xiaowen Bo, Qiuyu Li, Siyuan Chen, et al.
Journal of Cardiothoracic Surgery (2025) Vol. 20, Iss. 1
Open Access
Xiaowen Bo, Qiuyu Li, Siyuan Chen, et al.
Journal of Cardiothoracic Surgery (2025) Vol. 20, Iss. 1
Open Access
Discovery of miRNAs unique to actively transcribed erythroparvovirus infection in heart failure patients
Ganna Aleshcheva, S. Salih, Christian Baumeier, et al.
ESC Heart Failure (2025)
Open Access
Ganna Aleshcheva, S. Salih, Christian Baumeier, et al.
ESC Heart Failure (2025)
Open Access
The role of miR-21 as a biomarker and therapeutic target in cardiovascular disease
Fei He, Wanyi Guan
Clinica Chimica Acta (2025), pp. 120304-120304
Closed Access
Fei He, Wanyi Guan
Clinica Chimica Acta (2025), pp. 120304-120304
Closed Access
Pharmacokinetics and Proceedings in Clinical Application of Nucleic Acid Therapeutics
Markus Herkt, Thomas Thum
Molecular Therapy (2020) Vol. 29, Iss. 2, pp. 521-539
Open Access | Times Cited: 38
Markus Herkt, Thomas Thum
Molecular Therapy (2020) Vol. 29, Iss. 2, pp. 521-539
Open Access | Times Cited: 38
Cell type–specific microRNA therapies for myocardial infarction
Bohao Liu, Bryan Z. Wang, Xiaokan Zhang, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 580
Open Access | Times Cited: 32
Bohao Liu, Bryan Z. Wang, Xiaokan Zhang, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 580
Open Access | Times Cited: 32
Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches
Enrico Conte
Pharmacology & Therapeutics (2021) Vol. 234, pp. 108031-108031
Closed Access | Times Cited: 32
Enrico Conte
Pharmacology & Therapeutics (2021) Vol. 234, pp. 108031-108031
Closed Access | Times Cited: 32
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach
Luisa Marracino, Francesca Fortini, Esmaa Bouhamida, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 31
Luisa Marracino, Francesca Fortini, Esmaa Bouhamida, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 31
Identification of novel circulating microRNAs in advanced heart failure by next‐generation sequencing
Alessandro Galluzzo, Simona Gallo, Barbara Pardini, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 4, pp. 2907-2919
Open Access | Times Cited: 30
Alessandro Galluzzo, Simona Gallo, Barbara Pardini, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 4, pp. 2907-2919
Open Access | Times Cited: 30
Effect of mechanical unloading on genome-wide DNA methylation profile of the failing human heart
Xianghai Liao, Peter J. Kennel, Bohao Liu, et al.
JCI Insight (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 11
Xianghai Liao, Peter J. Kennel, Bohao Liu, et al.
JCI Insight (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 11
Is miR-21 A Therapeutic Target in Cardiovascular Disease?
Antoinette Holland, Molly Enrick, Arianna Diaz, et al.
International Journal of Drug Discovery and Pharmacology (2023), pp. 26-36
Open Access | Times Cited: 11
Antoinette Holland, Molly Enrick, Arianna Diaz, et al.
International Journal of Drug Discovery and Pharmacology (2023), pp. 26-36
Open Access | Times Cited: 11
Bone marrow‐fibroblast progenitor cell‐derived small extracellular vesicles promote cardiac fibrosis via miR‐21‐5p and integrin subunit αV signalling
Prabhat Ranjan, Roshan Kumar Dutta, Karen Colin, et al.
Journal of Extracellular Biology (2024) Vol. 3, Iss. 6
Open Access | Times Cited: 4
Prabhat Ranjan, Roshan Kumar Dutta, Karen Colin, et al.
Journal of Extracellular Biology (2024) Vol. 3, Iss. 6
Open Access | Times Cited: 4
Targeting miRNA‐1a and miRNA‐15b: A Novel Combinatorial Strategy to Drive Adult Cardiac Regeneration
Ting Yuan, Meiqian Wu, Chaonan Zhu, et al.
Advanced Science (2025)
Open Access
Ting Yuan, Meiqian Wu, Chaonan Zhu, et al.
Advanced Science (2025)
Open Access
Serum microRNAs are key predictors of long‐term heart failure and cardiovascular death after myocardial infarction
Leonardo Mejia Rincon, Macarena Rodríguez‐Serrano, Elisa Conde, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 5, pp. 3367-3379
Open Access | Times Cited: 17
Leonardo Mejia Rincon, Macarena Rodríguez‐Serrano, Elisa Conde, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 5, pp. 3367-3379
Open Access | Times Cited: 17
Non-coding RNA therapeutics in the treatment of heart failure
Aleksandra Paterek, Marta Załęska‐Kocięcka, Mateusz Surzykiewicz, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 4, pp. 353-360
Closed Access | Times Cited: 3
Aleksandra Paterek, Marta Załęska‐Kocięcka, Mateusz Surzykiewicz, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 4, pp. 353-360
Closed Access | Times Cited: 3
Exploring the role of pericardial miRNAs and exosomes in modulating cardiac fibrosis
Friederike I. Schoettler, Ali Fatehi Hassanabad, Anshul S. Jadli, et al.
Cardiovascular Pathology (2024) Vol. 73, pp. 107671-107671
Open Access | Times Cited: 3
Friederike I. Schoettler, Ali Fatehi Hassanabad, Anshul S. Jadli, et al.
Cardiovascular Pathology (2024) Vol. 73, pp. 107671-107671
Open Access | Times Cited: 3
Small extracellular vesicles associated miRNA in myocardial fibrosis
Minwen Long, Min Cheng
Biochemical and Biophysical Research Communications (2024) Vol. 727, pp. 150336-150336
Open Access | Times Cited: 3
Minwen Long, Min Cheng
Biochemical and Biophysical Research Communications (2024) Vol. 727, pp. 150336-150336
Open Access | Times Cited: 3
Emerging Role of Macrophage-Fibroblast Interactions in Cardiac Homeostasis and Remodeling
Xuzhe Zhang, Qin-Lin Li, Tingting Tang, et al.
JACC Basic to Translational Science (2024) Vol. 10, Iss. 1, pp. 113-127
Open Access | Times Cited: 3
Xuzhe Zhang, Qin-Lin Li, Tingting Tang, et al.
JACC Basic to Translational Science (2024) Vol. 10, Iss. 1, pp. 113-127
Open Access | Times Cited: 3
MicroRNAs—The Heart of Post-Myocardial Infarction Remodeling
Liana Maries, Cătălin Marian, Raluca Şoşdean, et al.
Diagnostics (2021) Vol. 11, Iss. 9, pp. 1675-1675
Open Access | Times Cited: 20
Liana Maries, Cătălin Marian, Raluca Şoşdean, et al.
Diagnostics (2021) Vol. 11, Iss. 9, pp. 1675-1675
Open Access | Times Cited: 20
MicroRNA-mediated control of myocardial infarction in diabetes
Daniel Pérez‐Cremades, Jingshu Chen, Carmel Assa, et al.
Trends in Cardiovascular Medicine (2022) Vol. 33, Iss. 4, pp. 195-201
Open Access | Times Cited: 13
Daniel Pérez‐Cremades, Jingshu Chen, Carmel Assa, et al.
Trends in Cardiovascular Medicine (2022) Vol. 33, Iss. 4, pp. 195-201
Open Access | Times Cited: 13